Form CERTNAS - Certification by the Nasdaq Stock Market approving securities for listing:
SEC Accession No. 9999999997-07-036149
Filing Date
2007-08-06
Accepted
2007-08-07 10:38:46
Documents
1
Effectiveness Date
2007-08-06

Document Format Files

Seq Description Document Type Size
1 AUTO-GENERATED PAPER DOCUMENT 9999999997-07-036149.paper CERTNAS 294
  Scanned paper document scanned.pdf   20898
  Complete submission text file 9999999997-07-036149.txt   1686
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: CERTNAS | Act: 34 | File No.: 001-33637 | Film No.: 07072772
SIC: 2834 Pharmaceutical Preparations